Orleans Capital Management Corp LA Has $3.65 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)
by Jessica Moore · The Cerbat GemOrleans Capital Management Corp LA lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 6.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,839 shares of the healthcare conglomerate’s stock after selling 470 shares during the quarter. UnitedHealth Group comprises approximately 2.1% of Orleans Capital Management Corp LA’s holdings, making the stock its 12th largest holding. Orleans Capital Management Corp LA’s holdings in UnitedHealth Group were worth $3,651,000 as of its most recent SEC filing.
A number of other hedge funds have also recently bought and sold shares of UNH. NewSquare Capital LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at $25,000. AlphaMark Advisors LLC bought a new position in shares of UnitedHealth Group during the 4th quarter worth about $30,000. Promus Capital LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at about $32,000. Pillar Financial Advisors LLC bought a new position in UnitedHealth Group during the fourth quarter worth about $40,000. Finally, DecisionPoint Financial LLC boosted its stake in UnitedHealth Group by 155.0% in the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after buying an additional 62 shares in the last quarter. 87.86% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
UNH has been the subject of several recent analyst reports. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $700.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. KeyCorp reiterated an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Barclays dropped their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Stephens lifted their target price on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. Finally, Oppenheimer raised their price target on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Twenty investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Buy” and an average target price of $629.32.
Get Our Latest Research Report on UnitedHealth Group
Insider Buying and Selling
In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. 0.33% of the stock is currently owned by corporate insiders.
UnitedHealth Group Stock Performance
UNH stock opened at $540.87 on Friday. The firm has a market cap of $494.74 billion, a PE ratio of 34.89, a P/E/G ratio of 1.37 and a beta of 0.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The business’s 50-day moving average price is $509.39 and its two-hundred day moving average price is $542.82. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. The business’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period last year, the company posted $5.83 EPS. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.55%. UnitedHealth Group’s dividend payout ratio is currently 54.19%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
- Five stocks we like better than UnitedHealth Group
- Short Selling – The Pros and Cons
- Shares of RH Down Nearly 40%: Where Investors Can Turn To Now
- Investing In Automotive Stocks
- Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian
- Basic Materials Stocks Investing
- Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).